|15.95||+0.52 / +3.37%|
As of 4:00pm ET
|15.95||0.00 / 0.00%|
The 6 analysts offering 12-month price forecasts for Epizyme Inc have a median target of 36.00, with a high estimate of 42.00 and a low estimate of 22.00. The median estimate represents a +125.71% increase from the last price of 15.95.
The current consensus among 7 polled investment analysts is to Buy stock in Epizyme Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.